Bupivacaine
NMCP.2024.0031
Phase 3 small_molecule active
Quick answer
Bupivacaine for Postoperative Pain is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Postoperative Pain
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active